Daymark Wealth Partners LLC Sells 7,064 Shares of The Procter & Gamble Company (NYSE:PG)

Daymark Wealth Partners LLC decreased its holdings in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 1.2% during the 1st quarter, Holdings Channel.com reports. The firm owned 590,743 shares of the company’s stock after selling 7,064 shares during the period. Procter & Gamble accounts for about 3.9% of Daymark Wealth Partners LLC’s investment portfolio, making the stock its 4th largest holding. Daymark Wealth Partners LLC’s holdings in Procter & Gamble were worth $95,848,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Advantage Trust Co acquired a new position in shares of Procter & Gamble in the 4th quarter valued at $28,000. Wyrmwood Management LLC purchased a new stake in Procter & Gamble during the fourth quarter valued at about $29,000. Naples Money Management LLC acquired a new stake in Procter & Gamble during the fourth quarter worth about $29,000. Transcendent Capital Group LLC purchased a new position in shares of Procter & Gamble in the 4th quarter worth about $31,000. Finally, Criterion Capital Advisors LLC acquired a new position in shares of Procter & Gamble in the 4th quarter valued at about $33,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Insider Activity

In other Procter & Gamble news, CEO Sundar G. Raman sold 31,924 shares of the firm’s stock in a transaction dated Monday, May 20th. The shares were sold at an average price of $166.95, for a total value of $5,329,711.80. Following the transaction, the chief executive officer now owns 19,042 shares of the company’s stock, valued at $3,179,061.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Procter & Gamble news, CEO Sundar G. Raman sold 31,924 shares of the stock in a transaction on Monday, May 20th. The stock was sold at an average price of $166.95, for a total value of $5,329,711.80. Following the sale, the chief executive officer now directly owns 19,042 shares of the company’s stock, valued at $3,179,061.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO R. Alexandra Keith sold 855 shares of the company’s stock in a transaction dated Monday, April 22nd. The stock was sold at an average price of $158.50, for a total transaction of $135,517.50. Following the transaction, the chief executive officer now owns 4,004 shares of the company’s stock, valued at approximately $634,634. The disclosure for this sale can be found here. In the last three months, insiders sold 154,544 shares of company stock valued at $25,413,051. Company insiders own 0.17% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently commented on the stock. StockNews.com lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating in a report on Monday, June 17th. Deutsche Bank Aktiengesellschaft reduced their target price on shares of Procter & Gamble from $172.00 to $171.00 and set a “buy” rating on the stock in a report on Monday, April 22nd. Truist Financial raised Procter & Gamble from a “hold” rating to a “buy” rating and raised their price objective for the company from $160.00 to $175.00 in a research report on Monday, March 11th. Argus upped their target price on Procter & Gamble from $180.00 to $185.00 and gave the stock a “buy” rating in a research report on Thursday, April 25th. Finally, The Goldman Sachs Group began coverage on Procter & Gamble in a report on Friday, March 1st. They set a “neutral” rating and a $168.00 target price on the stock. Seven research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $169.76.

Get Our Latest Stock Analysis on Procter & Gamble

Procter & Gamble Price Performance

Shares of PG stock opened at $168.26 on Friday. The firm has a market cap of $397.12 billion, a P/E ratio of 27.49, a P/E/G ratio of 3.40 and a beta of 0.42. The firm has a fifty day moving average of $164.59 and a two-hundred day moving average of $158.09. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.69 and a quick ratio of 0.48. The Procter & Gamble Company has a 1-year low of $141.45 and a 1-year high of $168.97.

Procter & Gamble (NYSE:PGGet Free Report) last announced its quarterly earnings data on Friday, April 19th. The company reported $1.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.10. The firm had revenue of $20.20 billion for the quarter, compared to analysts’ expectations of $20.43 billion. Procter & Gamble had a return on equity of 33.91% and a net margin of 18.00%. Procter & Gamble’s revenue for the quarter was up .6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.37 earnings per share. As a group, research analysts anticipate that The Procter & Gamble Company will post 6.55 earnings per share for the current fiscal year.

Procter & Gamble Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th were given a $1.0065 dividend. This is an increase from Procter & Gamble’s previous quarterly dividend of $0.94. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.39%. The ex-dividend date of this dividend was Thursday, April 18th. Procter & Gamble’s dividend payout ratio (DPR) is presently 65.85%.

About Procter & Gamble

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

See Also

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.